ANI Pharmaceuticals announces FDA approval and USP launch of trimethoprim tablets | Tech Reddy
[ad_1] BAUDET, Minn.–(BUSINESS WIRE)–ANI Pharmaceuticals, Inc. (ANI or Company) (Nasdaq: ANIP) announced today that it has received Abbreviated New Drug Application (ANDA) approval from the US Food and Drug Administration (FDA) for trimethoprim tablets USP, 100 mg. ANI’s Trimethoprim tablets are the generic version of the Reference List Drug (RLD) of the same brand name. … Read more